세계의 단일세포 멀티오믹스 시장 : 유형, 기술, 용도, 최종 사용자별 예측(2025-2030년)

The Single-Cell Multi-Omics Market was valued at USD 2.92 billion in 2023, expected to reach USD 3.18 billion in 2024, and is projected to grow at a CAGR of 10.65%, to USD 5.93 billion by 2030.

Single-cell multi-omics is an emerging field with significant potential in understanding the complexity of biological systems by simultaneously analyzing genomic, transcriptomic, proteomic, and epigenomic information at the single-cell level. This technique is critical in fields like cancer research, immunology, and personalized medicine. The necessity for single-cell multi-omics arises from its ability to provide a detailed molecular blueprint of individual cells, thus allowing researchers to comprehend cellular heterogeneity and identify rare cell populations, which could revolutionize diagnostics and therapeutics. Applications span across various segments, including drug discovery, biomarker identification, and disease pathway analysis. End-use sectors prominently impacted include pharmaceutical companies, academic research institutions, and biotechnology firms. Key growth factors influencing this market include advancements in sequencing technologies, increasing government funding for genomics research, and a rising focus on precision medicine. Opportunities for growth are particularly ripe in regions with burgeoning biotech sectors, like Asia-Pacific, where expanding healthcare infrastructure and growing investments in biotechnological research are expected to drive market expansion. However, the market faces challenges such as high costs associated with the technology, complex data interpretation, and the need for advanced bioinformatics capabilities. To capitalize on potential opportunities, companies should focus on developing cost-effective solutions, enhancing data analysis software, and forming strategic collaborations with academic and research institutions. Areas for innovation and research include improving the sensitivity and accuracy of single-cell multi-omics platforms, developing more effective data integration tools, and discovering novel applications in agriculture and environmental sciences. The market remains dynamic and highly competitive, necessitating continuous technological advancements and strategic adaptability to align with evolving research and clinical demands. For sustained growth, businesses should also invest in educational initiatives to increase awareness and understanding of the potential of single-cell multi-omics across various scientific sectors.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Single-Cell Multi-Omics Market

The Single-Cell Multi-Omics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of cancer cases and chronic disorders globally
  • Utilization of computational tools and bioinformatics strategies for single-cell omics
  • Need for adoption of single-cell multi-omics to accelerate drug discovery and development
• Market Restraints
  • High cost of multi-omics projects and lack of skilled personnel
• Market Opportunities
  • Adoption of AI and ML in single-cell multi-omics technologies
  • Emergence of epigenome, epitranscriptome, and other new omics
• Market Challenges
  • Difficult of analyzing large datasets and concerns associated with privacy of patient data

Porter's Five Forces: A Strategic Tool for Navigating the Single-Cell Multi-Omics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Single-Cell Multi-Omics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Single-Cell Multi-Omics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Single-Cell Multi-Omics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Single-Cell Multi-Omics Market

A detailed market share analysis in the Single-Cell Multi-Omics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Single-Cell Multi-Omics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Single-Cell Multi-Omics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Single-Cell Multi-Omics Market

A strategic analysis of the Single-Cell Multi-Omics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Single-Cell Multi-Omics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies, Inc., Akoya Biosciences, Becton, Dickinson and Company, Berkeley Lights Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, Cytena by Bico Group, Danaher Corporation, Dolomite Bio, Epicypher Inc., Illumina, Inc, Merck KGaA, Miltenyi Biotec B.V. & CO., Mission Bio, Inc., Nanostring Technologies, Inc., Olink Holding AB, Parse Bioscience, Qiagen NV, Standard BioTools Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., and Vizgen Inc..

Market Segmentation & Coverage

This research report categorizes the Single-Cell Multi-Omics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Single Cell Genomics, Single Cell Metabolomics, Single Cell Proteomics, and Single Cell Transcriptomics.
• Based on Technique, market is studied across Single-Cell Analysis and Single-Cell Isolation & Dispensing.
• Based on Application, market is studied across Cell Biology, Immunology, Neurology, Oncology, and Stem Cell Research.
• Based on End User, market is studied across Academic Institutes, Contract Research Organizations, and Pharmaceutical & Biotech Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of cancer cases and chronic disorders globally
    • 5.1.1.2. Utilization of computational tools and bioinformatics strategies for single-cell omics
    • 5.1.1.3. Need for adoption of single-cell multi-omics to accelerate drug discovery and development
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of multi-omics projects and lack of skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Adoption of AI and ML in single-cell multi-omics technologies
    • 5.1.3.2. Emergence of epigenome, epitranscriptome, and other new omics
  • 5.1.4. Challenges
    • 5.1.4.1. Difficult of analyzing large datasets and concerns associated with privacy of patient data
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Single-Cell Multi-Omics Market, by Type

• 6.1. Introduction
• 6.2. Single Cell Genomics
• 6.3. Single Cell Metabolomics
• 6.4. Single Cell Proteomics
• 6.5. Single Cell Transcriptomics

7. Single-Cell Multi-Omics Market, by Technique

• 7.1. Introduction
• 7.2. Single-Cell Analysis
• 7.3. Single-Cell Isolation & Dispensing

8. Single-Cell Multi-Omics Market, by Application

• 8.1. Introduction
• 8.2. Cell Biology
• 8.3. Immunology
• 8.4. Neurology
• 8.5. Oncology
• 8.6. Stem Cell Research

9. Single-Cell Multi-Omics Market, by End User

• 9.1. Introduction
• 9.2. Academic Institutes
• 9.3. Contract Research Organizations
• 9.4. Pharmaceutical & Biotech Companies

10. Americas Single-Cell Multi-Omics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Single-Cell Multi-Omics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Single-Cell Multi-Omics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics
• 2. Agilent Technologies, Inc.
• 3. Akoya Biosciences
• 4. Becton, Dickinson and Company
• 5. Berkeley Lights Inc.
• 6. BGI Genomics Co., Ltd.
• 7. Bio-Rad Laboratories, Inc.
• 8. Bruker Corporation
• 9. Cytena by Bico Group
• 10. Danaher Corporation
• 11. Dolomite Bio
• 12. Epicypher Inc.
• 13. Illumina, Inc
• 14. Merck KGaA
• 15. Miltenyi Biotec B.V. & CO.
• 16. Mission Bio, Inc.
• 17. Nanostring Technologies, Inc.
• 18. Olink Holding AB
• 19. Parse Bioscience
• 20. Qiagen NV
• 21. Standard BioTools Inc.
• 22. Takara Holdings Inc.
• 23. Thermo Fisher Scientific Inc.
• 24. Vizgen Inc.